E. Ohman J:Or Asset Management Ab Macrogenics Inc Transaction History

E. Ohman J:Or Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2017 Apr 05, 2024	SELL	$15.52 - $18.94 $3.06 Million - $3.73 Million	-197,002 Closed	0 $0
Q2 2017 Apr 05, 2024	BUY	N/A	102,455 Added 108.36%	197,002 $3.45 Billion
Q1 2017 Apr 05, 2024	BUY	N/A	40,662 Added 75.46%	94,547 $1.76 Billion
Q4 2016 Apr 05, 2024	BUY	N/A	9,950 Added 22.65%	53,885 $1.1 Billion
Q3 2016 Apr 05, 2024	BUY	N/A	43,935	43,935 $1.31 Billion

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.